論文一覧｜長崎大学熱帯医学研究所ウイルス学分野

学会発表

2021-09-11

Mizuki Fukuta

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

学会発表

2021-09-11

Mya Myat Ngwe Tun

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

論文発表

2021-09-03

Toru Takenaga, Zihan Zhang, Yukiko Muramoto, et al.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

その他

2021-08-01

Yuki Takamatsu

Yuki Takamatsu has been accepted for AMED 2021 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic) pathogen

その他

2021-07-21

Yuki Takamatsu

Yuki Takamatsu has been accepted by the "Takeda Science Foundation Medical Research Grant"

学会発表

2021-05-24

Jean Claude Balingit

The Impact of DENV-1 Genotypes on the Immune Response of Natural Homotypic Infections.

論文発表

2021-04-16

Shiori Sano, Shutetsu Fukushi, Souichi Yamada, et al.

Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus.

論文発表

2021-01-10

Mya Myat Ngwe Tun, Kazufumi Toume, Elizabeth Luvai, et al.

The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro

その他

2020-12-02

Yuki Takamatsu

Yuki Takamatsu has been accepted for the research grant: AMED Project multidisciplinary research area for 3 years.

論文発表

2020-11-11

Aung Kyaw Kyaw, Mya Myat Ngwe Tun, Takeshi Nabeshima, et al.

Paper

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

Yuki Takamatsu has been accepted for AMED 2021 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic) pathogen

Yuki Takamatsu has been accepted by the "Takeda Science Foundation Medical Research Grant"

The Impact of DENV-1 Genotypes on the Immune Response of Natural Homotypic Infections.

Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus.

The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro

Yuki Takamatsu has been accepted for the research grant: AMED Project multidisciplinary research area for 3 years.

Chikungunya Virus Infection in Blood Donors and Patients During Outbreak, Mandalay, Myanmar, 2019.

Paper

Discrepancies in infectivity of flavivirus and SARS-CoV-2 clinical samples: An Improved assay for infectious virus shedding and viremia assessment.

Effectiveness of the SA 14-14-2 Live-Attenuated Japanese Encephalitis Vaccine in Myanmar.

CP100356 Hydrochloride, a P-Glycoprotein Inhibitor, Inhibits Lassa Virus Entry: Implication of a Candidate Pan-Mammarenavirus Entry Inhibitor.

Yuki Takamatsu has been accepted for AMED 2021 Establishment of the research base for BSL-4 facility and capacity building of researchers on category I (highly pathogenic) pathogen

Yuki Takamatsu has been accepted by the &quot;Takeda Science Foundation Medical Research Grant&quot;

The Impact of DENV-1 Genotypes on the Immune Response of Natural Homotypic Infections.

Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus.

The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro

Yuki Takamatsu has been accepted for the research grant: AMED Project multidisciplinary research area for 3 years.

Chikungunya Virus Infection in Blood Donors and Patients During Outbreak, Mandalay, Myanmar, 2019.

Yuki Takamatsu has been accepted by the "Takeda Science Foundation Medical Research Grant"